1.Clinical features, endoscopic findings and outcome of ischemic colitis
Xuesong YANG ; Yumin LU ; Changfu YU
Chinese Journal of Digestion 1996;0(05):-
Objective To overview the clinical and endoscopic features of the ischemic colitis. Methods Retrospective analysis was conducted. Results Of the 60 cases, 87% were over 50 years, and females were more than males. 76.7% of the cases were associated with the basal diseases such as cardio cerebrovascular disorders, diabetes and hematological diseases as well as the history of abdominal operation. Colonoscopy showed mucosal edema, congestion, erosion and ulceration. 87.1% of the cases were cured after treatment and 16.7 % were improved. The outcome may be associated with the age, severity of the lesion, course, basal diseases and the complications. Conclusions Endoscopy plays a vital role in the early diagnosis of ischemic colitis.
2.Preliminary exploration of the influence factors on amplification of single cell duplex-nested PCR
Changgao ZHONG ; Luyun LI ; Changfu LU ; Ge LIN ; Guangxiu LU
Journal of Peking University(Health Sciences) 2004;0(01):-
Objective:To explore the influence factors on amplification of single cell duplex-nested PCR.Methods:The mutational loci region CD41-42 and IVS-Ⅱ654 of ?-globin gene were amplified by duplex-nested PCR with different combination of primers concentration, different Taq DNA polymerases, different neutralization buffers and with or without predenaturation at 98 ℃ before the PCR amplification in single lymphocyte or single blastomere, thus, to investigate the influence of these factors on the amplification efficiency of PCR.Results:TaKaRa EX Taq was the most efficient Taq DNA ploymerase among different Taq DNA ploymerases; primer pair R1+F1 at final concertration of 0.25 ?mol/L and R2+F2 at 0.3 ?mol/L were the most efficient ones in amplification among different combinations of primers concentrations; the amplification efficiency in neutralization buffer-1 (200 mmol/L Tricine) was obviously higher than that of neutralization buffer-2 (900 mmol/L Tris-HCl, pH 8.3/300 mmol/L KCl/200 mmol/L HCl)(P0.05). Conclusion:There were remarkable differences of the amplification efficiency of single cell duplex-nested PCR while using different combination of primers concentrations, different Taq DNA polymerases, different neutralization buffers. However, predenaturation at 98 ℃ before the single cell PCR amplification could not improve the PCR amplification efficiency
3.Analysis of the Causes of Total Fertilization Failure in Vitro Fertilization-Embryo Transfer
Jing DAI ; Zenghui HUANG ; Shuoping ZHANG ; Changfu LU ; Ge LIN
Progress in Modern Biomedicine 2017;17(27):5389-5391,5395
Fertilization is a crucial step for origin of life.During Assisted Reproductive Technologies (ART),total fertilization failure is complex and unpredictable.Total fertilization failure may related to some abnormal cellular mechanistic events,such as:any stage of sperm and cumulus-oocyte-complexes penetration,sperm-zona pellucida binding / penetration,sperm-oocyte membrane binding,oocyte activation,sperm discondensation or pronuclear formation.Most of total fertilization failure could be solved by intracytoplasmic sperm injection.But oocytes of some patient still can't fertilize successfully,even though assisted oocyte activation be used.As for total fertilization failure patients in ART,combining the mature of oocyte,sperm quality and some trail to improve clinical protocol in later cycle may prevent failure to happen again.
4.Influence of patient age and the number of good-quality-embryos transferred on multiple gestation in in vitro fertilization and embryo transfer
Shunji ZHANG ; Fei GONG ; Ge LIN ; Changfu LU ; Hongmei XIAO ; Guangxiu LU
Chinese Journal of Obstetrics and Gynecology 2008;43(8):567-570
Objective To observe the influence of patient′s age, and the number of transferred-good-quality-embryos on multiple gestation rates in in vitro fertilization and embryo transfer(IVF-ET) cycles. Methods In this retrospective study, a total of 4395 patients who transferred fresh embryo between Jan 2004 and Nov 2006 was analyzed. According to the age, the patients were divided into 2 groups: aged < 35 (3442 cycles) or aged ≥135(953 cycles). We regularly transferred 2 -3 embryos. If the patients had only one embryo, one was transferred. And those patients who had only 2 embryos, even if they were more than 35 years old or it would be the second time for them to transfer, were transferred 2 embryos. The influence of female age and the number of good quality embryos transferred on the multiple gestation rates in IVF-ET cycle was analyzed. Results (1)The multiple gestation rate of the groups of 1 good quality embryo,2 good quality embryos, or 3 good quality embryos transferred were 21.08% (35/166), 31.41% (413/1315), and 42. 37% (75/177), respectively in women aged < 35, with a significant difference between them. The pregnancy rates of these groups were 29. 64% (166/560) ,51.63% (1315/2547) ,and 52. 84% (177/335), respectively; there were no significant differences between 2 good quality embryos transferred group and 3 good quality embryos transferred group. (2) The multiple gestation rates of the groups of 1 good quality embryo,2 good quality embryos, or 3 good quality embryos transferred were 19. 51% (8/41) ,20. 65% (19/ 92) ,and 40.66% (74/182), respectively, in women aged ≥ 35; there were no significant differences between 1 good quality embryo transferred group and 2 good quality embryos transferred group. The pregnancy rates of these groups were 19. 07% (41/215), 33.70% (92/273), and 39. 14% (182/465), respectively; there were no significant differences between 2 good quality embryos transferred group and 3 good quality embryos transferred group. (3) The pregnancy rate of the patients aged <35 [48. 17% ( 1658/ 3442) ]was significantly higher than in women aged ≥35[33.05% (315/953) ]. Conclusion The transfer of 2 good quality embryos results in similar pregnancy rates and significantly reduced multiple gestation rates when compared to the transfer of 3 good quality embryos in women regardless of their ages.
5.Estrogen-like Effect of Tetrahydroxy Stilbene Glucoside and Its Effects on the Expression of ER in Uterus of Sexually Immature Mice
Can ZHU ; Yaofeng LI ; Fang PENG ; Tianqi CHEN ; Hai LU ; Cheng LIU ; Changfu YANG ; Hesheng WANG
China Pharmacy 2019;30(8):1031-1036
OBJECTIVE: To investigate estrogen-like effect of tetrahydroxy stilbene glucoside (TSG) and its effects on the expression of estrogen receptor (ER) in uterus of sexually immature mice. METHODS: Totally 60 sexually immature Kunming mice were randomly divided into normal group, positive control group (estradiol valerate, 0.18 mg/kg), TSG low-dose and high-dose groups (50, 150 mg/kg), TSG low-dose and high-dose groups+estradiol valerate groups (same dose as medication alone group). Normal group was given constant volume of water intragastrically, and administration groups were given relevant medicine 0.2 mL/10 g, once morning and night, for consecutive 5 d. The uterus index and body weight increase of mice in each group were determined and calculated the next day after the last administration. The contents of serum estrogen (E2, LH, FSH) were determined by ELISA. HE staining was used to observe the morphology characteristics of uterus, and uterine tube diameter and endometrial thickness were detected. The expression of ER(ER-α and ER-β) in uterus was detected by immunohistochemical staining. RESULTS: The myometrium of the mice in normal group was parallel and compact, the epithelium of the uterus was columnar, and the expression of ER-α and ER-β was low. The uterine tube diameter, endometrium and epithelium of mice in each administration group increased, thickened or proliferated in varying degrees, and the expression of ER-α and ER-β changed. Compared with normal group, uterus indexes (positive control group, TSG high-dose group, TSG+estradiol valerate groups), the increase of body weight (positive control group, TSG high-dose groups, TSG low-dose+estradiol valerate group), uterine tube diameter and endometrial thickness (positive control group, TSG low-dose group, TSG+estradiol valerate groups), the expression of ER-α (positive control group, TSG+estradiol valerate groups) and the expression of ER-β (postive control group, TSG high-dose+estradiol valerate group)were increased significantly, while serum contents of LH (positive control group, TSG high-dose group) and FSH (TSG low-dose+estradiol valerate group) were decreased significantly (P<0.05 or P<0.01). The uterus index, uterine tube diameter, endometrial thickness and the expression in ER-α and ER-β of TSG+estradiol valerate groups, the increase of body weight and serum content of E2 in TSG low-dose+estradiol valerate group were significantly higher than same TSG dose alone groups (P<0.05 or P<0.01). The uterus index, uterine tube diameter, endometrial thickness and the expression of ER-α and ER-β in TSG groups, uterine tube diameter and the expression of ER-β in TSG+estradiol valerate groups, body weight increase of mice in TSG low-dose group were significantly lower than positive control group, while serum content of LH in TSG+estradiol valerate groups were significantly higher than positive control group (P<0.05 or P<0.01). CONCLUSIONS: TSG can increase uterus indexes and body weight of sexually immature mice to certain extent, regulate estrogen level, increase the diameter of uterine tube and endometrial thickness and up-regulate the expression of ER in the uterus, showing certain estrogen-like effect, which is weaker than that of estradiol valerate. Combined use of them may antagonize the effect of estradiol valerate.
6.Working practices in eliminating the public health crisis caused by viral hepatitis in Hainan Province of China
Weihua LI ; Changfu XIONG ; Taifan CHEN ; Bin HE ; Dapeng YIN ; Xuexia ZENG ; Feng LIN ; Biyu CHEN ; Xiaomei ZENG ; Biao WU ; Juan JIANG ; Lu ZHONG ; Yuhui ZHANG
Journal of Clinical Hepatology 2025;41(2):228-233
In 2022, Hainan provincial government launched the project for the prevention and control of viral hepatitis with the goals of a hepatitis B screening rate of 90%, a diagnostic rate of 90%, and a treatment rate of 80% among people aged 18 years and above by the year 2025, and the main intervention measures include population-based prevention, case screening, antiviral therapy, and health management. As of December 31, 2024, a total of 6.875 million individuals in the general population had been screened for hepatitis B, with a screening rate of 95.6%. A total of 184 710 individuals with positive HBsAg were identified, among whom 156 772 were diagnosed through serological reexamination, resulting in a diagnostic rate of 84.9%. A total of 50 742 patients with chronic hepatitis B were identified, among whom 42 921 had hepatitis B-specific health records established for health management, with a file establishment rate of 84.6%. A total of 31 553 individuals received antiviral therapy, with a treatment rate of 62.2%. A total of 2.503 million individuals at a high risk of hepatitis C were screened, among whom 4 870 tested positive for HCV antibody and 3 858 underwent HCV RNA testing, resulting in a diagnostic rate of 79.2%, and 1 824 individuals with positive HCV RNA were identified, among whom 1 194 received antiviral therapy, with a treatment rate of 65.5%. In addition, 159 301 individuals with negative HBsAg and anti-HBs and an age of 20 — 40 years were inoculated with hepatitis B vaccine free of charge. Through the implementation of the project for the prevention and control of viral hepatitis, a large number of hepatitis patients have been identified, treated, and managed in the province within a short period of time, which significantly accelerates the efforts to eliminate the crisis of viral hepatitis.